Literature DB >> 2879961

Treatment of hypertension. Patterns of drug utilization in a metropolitan population.

W Koenig, U Keil, S Perz, J Stieber, A Döring.   

Abstract

In the Munich Blood Pressure Study (MBS), a cross-sectional study (MBS I) with follow-up (MBS II) of a random sample of 3,198 citizens aged 30-69 (response rate, 69.3%), treatment and control of hypertension were examined. Of the actual hypertensives 59% (221) in MBS II (373) were on drug treatment and about two-thirds (150) of those being treated had controlled blood pressure (BP). Women's BP was better controlled than men's. Of the 221 treated hypertensives 85% (188) received types of drugs or drug combinations which were in accordance with the recommendations of the German Hypertension League. However, this did not apply to the prescribed dosages of the various drugs. Of the treated hypertensives 52% were either on a diuretic, on a beta-blocker, or on a combination of both drugs. Rauwolfia alkaloids combined with a diuretic were given to 27%. In 79% of the participants who had received a beta-blocker either alone or in combination with other antihypertensive agents and who still had high BP values, the prescribed beta-blocker dosage was below the recommended daily dose. Fatigue was the most frequently reported symptom, possibly attributable to antihypertensive drug treatment. Electrocardiographic signs of left ventricular hypertrophy were found less frequently in controlled hypertensives, in comparison to treated but uncontrolled hypertensives or untreated hypertensives.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2879961     DOI: 10.1007/bf01734464

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  25 in total

Review 1.  Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications.

Authors:  W Frishman; R Silverman
Journal:  Am Heart J       Date:  1979-07       Impact factor: 4.749

2.  Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose.

Authors:  B J Materson; J R Oster; U F Michael; S M Bolton; Z C Burton; J E Stambaugh; J Morledge
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

3.  A point-score system for the ECG diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; E H Estes
Journal:  Am Heart J       Date:  1968-06       Impact factor: 4.749

4.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

5.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

6.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

7.  Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.

Authors:  J I Drayer; M A Weber; J M Gardin; J L Lipson
Journal:  Am J Med       Date:  1983-09-26       Impact factor: 4.965

Review 8.  Regression of left ventricular hypertrophy by medical treatment: present status and possible implications.

Authors:  R C Tarazi
Journal:  Am J Med       Date:  1983-09-26       Impact factor: 4.965

9.  Improvement in hypertension detection and control from 1973-1974 to 1980-1981. The Minnesota Heart Survey experience.

Authors:  A R Folsom; R V Luepker; R F Gillum; D R Jacobs; R J Prineas; H L Taylor; H Blackburn
Journal:  JAMA       Date:  1983-08-19       Impact factor: 56.272

10.  Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1982-02-05       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.